Overall Technical outlook

Price Summary

On 2026-06-03, Piramal Pharma Limited's stock began at 168.0, peaked at 169.3, declined to 164.71, and ended the day -0.59% lower at 167.01, with 2298152 shares traded.
Over the previous 52 weeks, the stock reached a high of 216.88 and a low of 133.27.

Technicals

Support and Resistance: The price sits at 167.01, supported by 163.05 and resisted by 171.79. This indicates a trading range where 163.05 provides a floor, preventing declines, and 171.79 acts as a ceiling, limiting further price increases for PPLPHARMA.
PPLPHARMA supportResistance db70f0
Support/Resistance for PPLPHARMA


Aroon: The AROON is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
PPLPHARMA aroon db70f0
Aroon chart for Piramal Pharma Limited


Bol. Bands: The BOLL BANDS is showing a neutral stance, not indicating a clear upward or downward trend for Piramal Pharma Limited. This suggests a period of market balance, where neither side is showing dominance.
PPLPHARMA bbands db70f0
Bolinger Bands chart for Piramal Pharma Limited


Parabolic SAR: The PSAR maintains a bearish stance, establishing a resistance level that could act as a barrier to any upward trends. This ongoing bearish outlook suggests that the market may continue to face resistance, keeping prices in check.
PPLPHARMA psar db70f0
Parabolic Stop and Reverse chart for Piramal Pharma Limited


Stochastic: The Stochastic K-line has dropped beneath the D-line and is below 20, indicating a mildly bearish outlook. This suggests that the market might experience some downward movement, though the bearish sentiment is mild. Investors should keep an eye on this trend for further confirmation.
PPLPHARMA stoch db70f0
Stochastic chart for Piramal Pharma Limited


Tripple Moving Agerage: The 20, 50, and 100 period moving averages are currently aligned in a bearish formation, reflecting a strong downtrend. Despite this, the slower SMAs appear to be losing steam, which might indicate a shift is on the horizon. This weakening bearish momentum could pave the way for a bullish reversal, as the market seems poised for a potential change in direction soon.
PPLPHARMA trippleSMA db70f0
Tripple SMA chart for Piramal Pharma Limited


A thorough analysis of a company involves looking beyond its stock price movements and trading patterns. You must also examine its fundamentals, which include profitability, growth prospects, and competitive advantages. Additionally, the industry in which the company operates provides important context, as factors like technological innovations, regulation, and market demand influence performance. By integrating this information with technical analysis, more accurate predictions about the company's future can be made.